2 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow lometrexol: new trials by email Literature Review of lometrexol trials Research Report on lometrexol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer folic acid, lometrexol - Lung Cancer | Phase 2 | Unknown | Tularik | 2002-02-01 | 2014-01-06 | |
| Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors folic acid, lometrexol, paclitaxel - Drug/Agent Toxicity by Tissue/Organ, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Unknown | Jonsson Comprehensive Cancer Center | 2001-09-01 | 2013-09-17 |
Adenocarcinoma of Lung (1) · Carcinoma, Non-Small-Cell Lung (1) · Drug-Related Side Effects and Adverse Reactions (1) · Lung Neoplasms (1)
Jonsson Comprehensive Cancer Center (1) · Tularik (1)
United States (2)
David Tesarowski (1) · Lee S. Rosen, MD (1)